Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amoretti

Showing results (291-300 of 346) with videos related to

Pageof 35
Sort By:
Schizophrenia Research|March 1, 2022
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophreniaMiquel Bioque, Gisela Mezquida, Sílvia Amoretti, et al.
Journal of Clinical Medicine|July 2, 2021
The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of PsychosisMariola Molina-García, David Fraguas, Ángel Del Rey-Mejías, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 16, 2024
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up studyDerek Clougher, Maria Florencia Forte, Gisela Mezquida, et al.
Schizophrenia Research|December 3, 2023
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinationsGracian Garcia-Marti, Maria J Escarti, Juan Nacher, et al.
Spanish Journal of Psychiatry and Mental Health|September 16, 2023
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patientsGisela Mezquida, Silvia Amoretti, Miquel Bioque, et al.
Diabetes/Metabolism Research and Reviews|August 10, 1999
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI)N Visalli, M G Cavallo, A Signore, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 10, 2022
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up studyAna M Sánchez-Torres, Silvia Amoretti, Mónica Enguita-Germán, et al.
Cell Host & Microbe|June 17, 2023
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremiaJonas Schluter, Ana Djukovic, Bradford P Taylor, et al.
European Journal of Endocrinology|October 23, 1997
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)P Pozzilli, N Visalli, M G Cavallo, et al.
Blood|August 15, 2022
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host diseaseMarina Burgos da Silva, Doris M Ponce, Anqi Dai, et al.
Pageof 35

Showing results (291-300 of 346) with videos related to

Sort By:
Pageof 35
Schizophrenia Research|March 1, 2022
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophreniaMiquel Bioque, Gisela Mezquida, Sílvia Amoretti, et al.
Journal of Clinical Medicine|July 2, 2021
The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of PsychosisMariola Molina-García, David Fraguas, Ángel Del Rey-Mejías, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 16, 2024
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up studyDerek Clougher, Maria Florencia Forte, Gisela Mezquida, et al.
Schizophrenia Research|December 3, 2023
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinationsGracian Garcia-Marti, Maria J Escarti, Juan Nacher, et al.
Spanish Journal of Psychiatry and Mental Health|September 16, 2023
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patientsGisela Mezquida, Silvia Amoretti, Miquel Bioque, et al.
Diabetes/Metabolism Research and Reviews|August 10, 1999
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI)N Visalli, M G Cavallo, A Signore, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 10, 2022
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up studyAna M Sánchez-Torres, Silvia Amoretti, Mónica Enguita-Germán, et al.
Cell Host & Microbe|June 17, 2023
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremiaJonas Schluter, Ana Djukovic, Bradford P Taylor, et al.
European Journal of Endocrinology|October 23, 1997
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)P Pozzilli, N Visalli, M G Cavallo, et al.
Blood|August 15, 2022
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host diseaseMarina Burgos da Silva, Doris M Ponce, Anqi Dai, et al.
Pageof 35